You are here: Industry Insights > coeliac disease

News List

Takeda acquires PvP Biologics following coeliac disease drug trial europeanpharmaceuticalreview
March 03, 2020
A statement by the Takeda reveals the company has acquired PvP as part of a development and option agreement for the drug TAK-062.
First Rare Disease Collaborative Network for refractory coeliac disease pharmatimes
November 22, 2018
Refractory coeliac disease, a deadly form of the autoimmune condition coeliac disease, has received its first dedicated support from NHS England, with the setting up of a Rare
Coeliac UK launches new research fund and appeal pharmatimes
July 23, 2018
Coeliac UK has launched a new research fund and fundraising appeal that aims to raise £5 million to improve understanding and management of coeliac disease and gluten related autoimmune conditions.
Experimental drug eases effects of gluten for coeliac patients on gluten-free diet europeanpharmaceuticalreview
May 29, 2018
First proof-of-concept study shows AMG 714 (anti-IL-15 monoclonal antibody) potentially protects celiac patients from inadvertent gluten exposure